Short answer
Syndax Pharmaceuticals Inc (SNDX) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2025 earnings press release referenced via exhibit: full financial results in accompanying exhibit, not inline text.
Syndax Pharmaceuticals Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2025 earnings press release referenced via exhibit: full financial results in accompanying exhibit, not inline text
- Boilerplate language confirms results disclosure is Reg FD-compliant but not incorporated by reference into SEC filings
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Syndax Pharmaceuticals Inc 8-K filings
Get the next SNDX 8-K as it lands
Follow SNDX for push alerts, or ask the research agent what this filing means.